128 related articles for article (PubMed ID: 3838397)
1. Proceedings of the International Symposium on Molsidomine. November 5, 1983, Brussels, Belgium.
Am Heart J; 1985 Mar; 109(3 Pt 2):625-724. PubMed ID: 3838397
[No Abstract] [Full Text] [Related]
2. [We need molsidomine for complete prevention of ischemia. Interview with Prof. Rudolph on the therapy of coronary heart disease].
Rudolph W
Fortschr Med; 1986 Apr; 104(13):52. PubMed ID: 3754533
[No Abstract] [Full Text] [Related]
3. Hemodynamic effects of molsidomine in patients with heart failure following acute myocardial infarction.
Cantelli I; Lolli C; Brunelli A; Bracchetti D
Am Heart J; 1985 Mar; 109(3 Pt 2):716-9. PubMed ID: 3838410
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of molsidomin in ischemic cardiopathy].
Di Giacomo G; Nicolella U; Puligheddu M; Tripodi A; D'Ascoli C; Di Virgilio D
Clin Ter; 1984 Oct; 111(2):141-6. PubMed ID: 6239736
[No Abstract] [Full Text] [Related]
5. [Effectiveness and duration of effect of molsidomine and isosorbide dinitrate in peripheral circulation].
König FK; Grewe R; Wörz K
Fortschr Med; 1985 Oct; 103(38):903-6. PubMed ID: 3908257
[No Abstract] [Full Text] [Related]
6. [Treatment with sidnonimine derivatives of chronic ischemic heart disease patients].
Kuz'ko NV
Vrach Delo; 1984 Jul; (7):79-81. PubMed ID: 6548063
[No Abstract] [Full Text] [Related]
7. Effects of molsidomine on hemodynamics and blood gases in acute myocardial infarction with left heart failure.
Renard M; Jacobs P; Liebens I; Friart A; Bernard R
Am Heart J; 1985 Mar; 109(3 Pt 2):720-2. PubMed ID: 3919551
[TBL] [Abstract][Full Text] [Related]
8. Effects of molsidomine on left ventricular dimensions and cardiac function in patients with chronic heart failure.
Berkenboom GM; Sobolski JC; Vandermoten PP; Stoupel EE; Degre SG
Am Heart J; 1985 Mar; 109(3 Pt 2):691-3. PubMed ID: 3838405
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical and hemodynamic results of molsidomine treatment in patients with refractory heart failure.
Acar J; Kulas A; Escudier B
Am Heart J; 1985 Mar; 109(3 Pt 2):685-7. PubMed ID: 3883737
[TBL] [Abstract][Full Text] [Related]
10. [Molsidomin in coronary disease. Clinico-pharmacokinetic correlation study on the effect of oral and sublingual therapy].
Strasser R; Klepzig H; Ostrowski J; Resag K
MMW Munch Med Wochenschr; 1983 Feb; 125(8):156-8. PubMed ID: 6405248
[No Abstract] [Full Text] [Related]
11. Prevention with molsidomine of coronary artery spasm caused by alkalosis.
Weber S; Kahan A; Pailleret JJ; Guérin F; Degeorges M
Am Heart J; 1985 Mar; 109(3 Pt 2):704-7. PubMed ID: 3838408
[TBL] [Abstract][Full Text] [Related]
12. The activity of molsidomine in experimental models of ischemic cardiac disease.
Nitz RE; Martorana PA
Am Heart J; 1985 Mar; 109(3 Pt 2):631-6. PubMed ID: 3919549
[TBL] [Abstract][Full Text] [Related]
13. [Effect of molsidomin and nifedipine on tolerance of physical exertion among rheumatic fever patients in the initial stage of heart failure].
Sokolov AM
Vrach Delo; 1986 Jan; (1):32-5. PubMed ID: 3754076
[No Abstract] [Full Text] [Related]
14. Haemodynamic effects of molsidomine in patients with severe chronic coronary disease.
Crexells C; Lidón RM; Augé JM; Bosch X; Pina C; Garcia J; Oriol A
Eur Heart J; 1985 Dec; 6(12):1032-9. PubMed ID: 3841658
[TBL] [Abstract][Full Text] [Related]
15. The influence of molsidomine on the hemodynamics of patients with chronic heart failure at rest and during exercise.
Larbig DT; Milstrey HR; Nasse H; Kahle T
Am Heart J; 1985 Mar; 109(3 Pt 2):688-90. PubMed ID: 3883738
[TBL] [Abstract][Full Text] [Related]
16. [Effect of korvatone on the hemodynamic indices of rheumatism patients].
Sokolov AM; Suloeva MN
Vrach Delo; 1984 Jul; (7):83-6. PubMed ID: 6548064
[No Abstract] [Full Text] [Related]
17. [Clinical study of the preparation korvatone].
Charchoglian RA; Esin NN; Belozerov GE
Sov Med; 1982; (5):15-8. PubMed ID: 7051350
[No Abstract] [Full Text] [Related]
18. Effectiveness of molsidomine in the long-term treatment of exertional angina pectoris and chronic congestive heart failure.
Rudolph W; Dirschinger J
Am Heart J; 1985 Mar; 109(3 Pt 2):670-4. PubMed ID: 3883733
[TBL] [Abstract][Full Text] [Related]
19. Exercise tolerance in coronary patients: randomized trial of two-week treatment with molsidomine versus placebo.
Messin R
Am Heart J; 1985 Mar; 109(3 Pt 2):667-9. PubMed ID: 3883732
[TBL] [Abstract][Full Text] [Related]
20. Molsidomine in the treatment of acute heart failure.
Drajer S; Vazquez A; Cercós H; Torres H; Cohn JL; Romero N; Faerman G; Soifer S; Nijensohn CM
Am Heart J; 1985 Mar; 109(3 Pt 2):712-5. PubMed ID: 3838409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
